Drug Type Stem cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic graft-versus-host disease | Phase 2 | South Korea | 30 Jan 2022 | |
| Dermatitis, Atopic | Phase 2 | South Korea | 30 Jan 2022 | |
| Pancreatitis | Phase 2 | South Korea | 30 Jan 2022 | |
| Respiratory Distress Syndrome, Adult | Phase 1 | South Korea | 16 Nov 2021 | |
| Cerebellar Ataxia | Phase 1 | South Korea | 14 Mar 2020 |





